Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study.

Xhaard A, Roque-Afonso AM, Mallet V, Ribaud P, Nguyen-Quoc S, Rohrlich PS, Tabrizi R, Konopacki J, Lissandre S, Abravanel F, Latour RP, Huynh A.

Viruses. 2019 Jul 5;11(7). pii: E622. doi: 10.3390/v11070622.

2.

European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia.

Maertens JA, Girmenia C, Brüggemann RJ, Duarte RF, Kibbler CC, Ljungman P, Racil Z, Ribaud P, Slavin MA, Cornely OA, Peter Donnelly J, Cordonnier C; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and; European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) .

J Antimicrob Chemother. 2018 Dec 1;73(12):3221-3230. doi: 10.1093/jac/dky286.

PMID:
30085172
3.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

4.

[French recommendations on control measures to reduce the infectious risk in immunocompromised patients].

Zahar JR, Jolivet S, Adam H, Dananché C, Lizon J, Alfandari S, Boulestreau H, Baghdadi N, Bay JO, Bénéteau AM, Bougnoux ME, Brenier-Pinchart MP, Dalle JH, Fournier S, Fuzibet JG, Kauffmann-Lacroix C, Le Guinche I, Lepelletier D, Loukili N, Lory A, Morvan M, Oumedaly R, Ribaud P, Rohrlich P, Vanhems P, Aho S, Vanjak D, Gangneux JP.

J Mycol Med. 2017 Dec;27(4):449-456. doi: 10.1016/j.mycmed.2017.10.004. Epub 2017 Nov 11. Review. French.

PMID:
29132793
5.

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M.

Ann Intensive Care. 2016 Dec;6(1):90. doi: 10.1186/s13613-016-0189-6. Epub 2016 Sep 15. Review.

6.

Reply to "Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation".

Cornetto MA, de Margerie-Mellon C, Ribaud P, Bergeron A.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1910. doi: 10.1016/j.bbmt.2016.07.004. Epub 2016 Jul 12. No abstract available.

7.

Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation.

Cornetto MA, Chevret S, Abbes S, de Margerie-Mellon C, Hussenet C, Sicre de Fontbrune F, Tazi A, Ribaud P, Bergeron A.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1511-1516. doi: 10.1016/j.bbmt.2016.05.009. Epub 2016 May 14.

8.

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.

Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O; French Mycosis Study Group.

J Antimicrob Chemother. 2015 Nov;70(11):3116-23. doi: 10.1093/jac/dkv236. Epub 2015 Aug 27.

PMID:
26316385
9.

Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.

Granier C, Biard L, Masson E, Porcher R, Peffault de Latour R, Robin M, Boissel N, Xhaard A, Ribaud P, Lengline E, Larghero J, Charron D, Loiseau P, Socié G, Dhédin N.

Am J Hematol. 2015 Oct;90(10):897-903. doi: 10.1002/ajh.24112. Epub 2015 Aug 14.

10.

Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial.

Cordonnier C, Labopin M, Robin C, Ribaud P, Cabanne L, Chadelat C, Cesaro S, Ljungman P.

Bone Marrow Transplant. 2015 Jul;50(7):978-83. doi: 10.1038/bmt.2015.42. Epub 2015 Apr 13.

PMID:
25867652
11.

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.

Kheav VD, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P, Mazeron MC, Carmagnat M, Masson E, Xhaard A, Robin M, Ribaud P, Dulphy N, Loiseau P, Charron D, Socié G, Toubert A, Moins-Teisserenc H.

Haematologica. 2014 Dec;99(12):1860-7. doi: 10.3324/haematol.2014.108407. Epub 2014 Aug 1.

12.

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.

Xhaard A, Moins-Teisserenc H, Busson M, Robin M, Ribaud P, Dhedin N, Abbes S, Carmagnat M, Kheav VD, Maki G, Peffault de Latour R, Toubert A, Socié G.

Bone Marrow Transplant. 2014 Aug;49(8):1089-92. doi: 10.1038/bmt.2014.105. Epub 2014 May 19.

PMID:
24842524
13.

Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Sulahian A, Porcher R, Bergeron A, Touratier S, Raffoux E, Menotti J, Derouin F, Ribaud P.

J Clin Microbiol. 2014 Jul;52(7):2328-33. doi: 10.1128/JCM.03567-13. Epub 2014 Apr 16.

14.

Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome.

Wolfromm A, Porcher R, Legoff J, Peffault de Latour R, Xhaard A, de Fontbrune FS, Ribaud P, Bergeron A, Socié G, Robin M.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1238-41. doi: 10.1016/j.bbmt.2014.04.004. Epub 2014 Apr 13.

15.

Disseminated cutaneous infection due to Mycobacterium chelonae following hematopoietic stem cell transplantation.

Ferry C, Saussine A, Bouaziz JD, Xhaard A, Peffault de Latour R, Ribaud P, Robin M, Cambau E, Socié G.

IDCases. 2014 Jul 25;1(4):68-9. doi: 10.1016/j.idcr.2014.07.002. eCollection 2014.

16.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.

Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape P, Thiébaut A, Le Goff J, Autran B, Ribaud P.

Vaccine. 2014 Jan 23;32(5):585-91. doi: 10.1016/j.vaccine.2013.11.073. Epub 2013 Dec 12.

PMID:
24333120
17.

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors.

Servais S, Porcher R, Xhaard A, Robin M, Masson E, Larghero J, Ribaud P, Dhedin N, Abbes S, Sicre F, Socié G, Peffault de Latour R.

Haematologica. 2014 Mar;99(3):519-26. doi: 10.3324/haematol.2013.089979. Epub 2013 Nov 15.

18.

Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.

Schnepf N, Dhédin N, Mercier-Delarue S, Andreoli A, Mamez AC, Ferry C, Deback C, Ribaud P, Robin M, Socié G, Simon F, Mazeron MC.

J Clin Virol. 2013 Dec;58(4):733-6. doi: 10.1016/j.jcv.2013.10.007. Epub 2013 Oct 16.

PMID:
24183928
19.

Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.

Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E.

J Antimicrob Chemother. 2014 Feb;69(2):500-5. doi: 10.1093/jac/dkt376. Epub 2013 Oct 3.

PMID:
24092659
20.

False positive galactomannan test after ice-pop ingestion.

Guigue N, Menotti J, Ribaud P.

N Engl J Med. 2013 Jul 4;369(1):97-8. doi: 10.1056/NEJMc1210430. No abstract available.

PMID:
23822795
21.

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

de Masson A, Bouaziz JD, Peffault de Latour R, Wittnebel S, Ribaud P, Rubio MT, Micol JB, Suarez F, Nguyen S, Dalle JH, Yakouben K, Robin M, Xhaard A, Adès L, Bourhis JH, Rybojad M, Bagot M, Socié G.

Blood. 2012 Dec 13;120(25):5089-90. doi: 10.1182/blood-2012-09-453928. No abstract available.

22.

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.

Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socié G, Tazi A.

Bone Marrow Transplant. 2013 Jun;48(6):819-24. doi: 10.1038/bmt.2012.241. Epub 2012 Dec 3.

PMID:
23208317
23.

Increased infection rate after preemptive rituximab treatment for Epstein-Barr virus reactivation after allogeneic hematopoietic stem-cell transplantation.

Petropoulou AD, Porcher R, Peffault de Latour R, Xhaard A, Weisdorf D, Ribaud P, Rodriguez-Otero P, Agbalika F, Talbot A, Toubert A, Moins-Teisserenc H, Carmagnat M, Socié G, Robin M.

Transplantation. 2012 Oct 27;94(8):879-83. doi: 10.1097/TP.0b013e3182664042.

PMID:
23001354
24.

I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.

LeGoff J, Rousset D, Abou-Jaoudé G, Scemla A, Ribaud P, Mercier-Delarue S, Caro V, Enouf V, Simon F, Molina JM, van der Werf S.

PLoS One. 2012;7(8):e37095. doi: 10.1371/journal.pone.0037095. Epub 2012 Aug 24.

25.

Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.

Resche-Rigon M, Pirracchio R, Robin M, De Latour RP, Sibon D, Ades L, Ribaud P, Fermand JP, Thieblemont C, Socié G, Chevret S.

BMC Blood Disord. 2012 Aug 16;12:10. doi: 10.1186/1471-2326-12-10.

26.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

Xhaard A, Lanternier F, Porcher R, Dannaoui E, Bergeron A, Clement L, Lacroix C, Herbrecht R, Legrand F, Mohty M, Michallet M, Cordonnier C, Malak S, Guyotat D, Couderc LJ, Socié G, Milpied N, Lortholary O, Ribaud P.

Clin Microbiol Infect. 2012 Oct;18(10):E396-400. doi: 10.1111/j.1469-0691.2012.03908.x. Epub 2012 Jun 4.

27.

Response assessment in invasive aspergillosis.

Bergeron A, Porcher R, Raffoux E, Sulahian A, Ribaud P.

Clin Infect Dis. 2012 Aug;55(3):475-6; author reply 476-7. doi: 10.1093/cid/cis415. Epub 2012 May 4. No abstract available.

PMID:
22563023
28.

Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.

Rodriguez-Otero P, Porcher R, Peffault de Latour R, Contreras M, Bouhnik Y, Xhaard A, Andreoli A, Ribaud P, Kapel N, Janin A, Socié G, Robin M.

Blood. 2012 Jun 14;119(24):5909-17. doi: 10.1182/blood-2011-12-397968. Epub 2012 May 3.

29.

Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications.

Hirsch P, Leclerc M, Rybojad M, Petropoulou AD, Robin M, Ribaud P, de la Tour RP, Cavelier-Balloy B, Socié G, Vexiau-Robert D.

Transplantation. 2012 Jun 27;93(12):1265-9. doi: 10.1097/TP.0b013e31824f3dcd.

PMID:
22466789
30.

Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.

De Castro N, Mazoyer E, Porcher R, Raffoux E, Suarez F, Ribaud P, Lortholary O, Molina JM.

Clin Microbiol Infect. 2012 Jun;18(6):E185-7. doi: 10.1111/j.1469-0691.2012.03819.x. Epub 2012 Mar 28.

31.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

32.

Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.

Salmeron G, Porcher R, Bergeron A, Robin M, Peffault de Latour R, Ferry C, Rocha V, Petropoulou A, Xhaard A, Lacroix C, Sulahian A, Socié G, Ribaud P.

Haematologica. 2012 Sep;97(9):1357-63. doi: 10.3324/haematol.2011.058255. Epub 2012 Feb 27.

33.

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.

Konopacki J, Porcher R, Robin M, Bieri S, Cayuela JM, Larghero J, Xhaard A, Andreoli AL, Dhedin N, Petropoulou A, Rodriguez-Otero P, Ribaud P, Moins-Teisserenc H, Carmagnat M, Toubert A, Chalandon Y, Socie G, Peffault de Latour R.

Haematologica. 2012 May;97(5):710-6. doi: 10.3324/haematol.2011.050096. Epub 2011 Dec 16.

34.

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2012 Mar;50(3):823-30. doi: 10.1128/JCM.00750-11. Epub 2011 Dec 14.

35.

The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.

Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, Ribaud P.

Blood. 2012 Feb 23;119(8):1831-7; quiz 1956. doi: 10.1182/blood-2011-04-351601. Epub 2011 Oct 18.

36.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.

Marks DI, Pagliuca A, Kibbler CC, Glasmacher A, Heussel CP, Kantecki M, Miller PJ, Ribaud P, Schlamm HT, Solano C, Cook G; IMPROVIT Study Group.

Br J Haematol. 2011 Nov;155(3):318-27. doi: 10.1111/j.1365-2141.2011.08838.x. Epub 2011 Aug 22.

37.

Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis.

Burghi G, Lemiale V, Seguin A, Lambert J, Lacroix C, Canet E, Moreau AS, Ribaud P, Schnell D, Mariotte E, Schlemmer B, Azoulay E.

Intensive Care Med. 2011 Oct;37(10):1605-12. doi: 10.1007/s00134-011-2344-8. Epub 2011 Aug 25.

PMID:
21866367
38.

Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.

Lorillon G, Robin M, Meignin V, Ribaud P, Lescoeur B, Gossot D, Socié G, Tazi A, Bergeron A.

Eur Respir J. 2011 Aug;38(2):470-2. doi: 10.1183/09031936.00003711. No abstract available.

39.

The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.

Pichereau C, Desseaux K, Janin A, Scieux C, Peffault de Latour R, Xhaard A, Robin M, Ribaud P, Agbalika F, Chevret S, Socié G.

Biol Blood Marrow Transplant. 2012 Jan;18(1):141-4. doi: 10.1016/j.bbmt.2011.07.018. Epub 2011 Jul 27.

40.

Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment.

Xhaard A, Rocha V, Bueno B, de Latour RP, Lenglet J, Petropoulou A, Rodriguez-Otero P, Ribaud P, Porcher R, Socié G, Robin M.

Biol Blood Marrow Transplant. 2012 Mar;18(3):406-13. doi: 10.1016/j.bbmt.2011.06.012. Epub 2011 Jul 4.

41.

Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure.

Mariotte E, Schnell D, Scieux C, Agbalika F, Legoff J, Ribaud P, Boissel N, Schlemmer B, Azoulay E.

Infection. 2011 Jun;39(3):225-30. doi: 10.1007/s15010-011-0114-8. Epub 2011 May 3.

PMID:
21538037
42.

Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.

Ruggeri A, Peffault de Latour R, Carmagnat M, Clave E, Douay C, Larghero J, Cayuela JM, Traineau R, Robin M, Madureira A, Ribaud P, Ferry C, Devergie A, Purtill D, Rabian C, Gluckman E, Toubert A, Socié G, Rocha V.

Transpl Infect Dis. 2011 Oct;13(5):456-65. doi: 10.1111/j.1399-3062.2011.00632.x. Epub 2011 Apr 5.

PMID:
21466640
43.

Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.

Michallet M, Gangneux JP, Lafuma A, Herbrecht R, Ribaud P, Caillot D, Dupont B, Moreau P, Berger P, O'Sullivan AK.

J Med Econ. 2011;14(1):28-35. doi: 10.3111/13696998.2010.542393. Epub 2010 Dec 23.

PMID:
21175376
44.

Skin Microvascular Thrombosis in Fusarium Infection in Two Early Biopsied Cases.

Fan Y, Willems L, Leboeuf C, Li W, Lacroix C, Robin M, Socié G, Ribaud P, Verneuil L, Janin A.

Case Rep Dermatol. 2010 May 7;2(2):76-81.

45.

Nephrotic syndrome associated with graft rejection after unrelated double cord blood transplantation.

Petropoulou AD, Robin M, Rocha V, Ribaud P, Xhaard A, Abboud I, Peffault de Latour R, Socié G, Peraldi MN.

Transplantation. 2010 Oct 15;90(7):801-2. doi: 10.1097/TP.0b013e3181ee4431. No abstract available.

PMID:
20881580
46.

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.

Thepot S, Zhou J, Perrot A, Robin M, Xhaard A, de Latour RP, Ades L, Ribaud P, Petropoulou AD, Porcher R, Socié G.

Leukemia. 2010 Nov;24(11):1852-8. doi: 10.1038/leu.2010.187. Epub 2010 Sep 9.

PMID:
20827288
47.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, Gachot B, Heinz WJ, Lass-Flörl C, Ribaud P, Thiebaut A, Cordonnier C; Third European Conference on Infections in Leukemia.

Bone Marrow Transplant. 2011 May;46(5):709-18. doi: 10.1038/bmt.2010.175. Epub 2010 Jul 26.

PMID:
20661235
48.

Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis.

Robin M, Espérou H, de Latour RP, Petropoulou AD, Xhaard A, Ribaud P, Socié G.

Br J Haematol. 2010 Sep;150(6):721-4. doi: 10.1111/j.1365-2141.2010.08276.x. No abstract available.

PMID:
20618333
49.

Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.

Blin N, Traineau R, Houssin S, Peffault de Latour R, Petropoulou A, Robin M, Larghero J, Ribaud P, Socié G.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1315-23. doi: 10.1016/j.bbmt.2010.03.021. Epub 2010 Mar 29.

50.

Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation.

Petropoulou AD, Porcher R, Herr AL, Devergie A, Brentano TF, Ribaud P, Pinto FO, Rocha V, Peffault de Latour R, Orcel P, Socié G, Robin M.

Transplantation. 2010 Jun 15;89(11):1354-61. doi: 10.1097/TP.0b013e3181d84c8e.

PMID:
20216480

Supplemental Content

Loading ...
Support Center